A review on the variable copies of C-C motif chemokine ligand 3 like 1 (CCL3L1) gene among different populations and current methods for quantification

A review on the variable copies of C-C motif chemokine ligand 3 like 1 (CCL3L1) gene among different populations and current methods for quantification

C-C motif Chemokine Ligand 3 Like 1 (CCL3L1) is characterized as a gene with copy number variable (CNV) and clustered at the segmental duplication on chromosome 17q12. CCL3L1 is responsible for the production of macrophage inflammatory protein (MIP) 1α that plays an important function in the immune...

Full description

Bibliographic Details
Main Authors:	Jamaluddin, Jalilah, Abu Bakar @ Jamaludin, Suhaili
Format:	Article
Language:	English
Published:	Faculty of Medicine and Health Sciences, Universiti Putra Malaysia 2019
Online Access:	http://psasir.upm.edu.my/id/eprint/70061/1/2019070210042014_MJMHS_SP2_2019.pdf

Similar Items

Population-specific profiling of CCL3L1 copy number of the three major ethnic groups in Malaysia and the implication on HIV susceptibility
by: Mohamad Isa, Irma Izani, et al.
Published: (2020)

C-C Motif Chemokine Ligand 5 (CCL5) Promotes Irradiation-Evoked Osteoclastogenesis
by: Jing Wang, et al.
Published: (2023-11-01)

Chemokine (C-C motif) ligand 2 (CCL2) in sera of patients with type 1 diabetes and diabetic complications.
by: Ruili Guan, et al.
Published: (2011-04-01)

Copy number variation of CCL3L1 among three major ethnic groups in Malaysia
by: Jamaluddin, Jalilah, et al.
Published: (2020)

Copy number variation of CCL3L1 among three major ethnic groups in Malaysia
by: Jalilah Jamaluddin, et al.
Published: (2020-01-01)

Distribution of CCL3L1 copy number variable gene among three major ethnic groups in Malaysia
by: Jamaluddin, Jalilah
Published: (2017)

Copy number variation of c-c chemokine ligand 3-like 1 (CCL3L1), c-c chemokine receptor type 5 (CCR5) and CCR2 polymorphisms on the outcomes of antiretroviral therapy among Malaysian HIV patients
by: Mohamad Isa, Irma Izani
Published: (2020)

Does C-C Motif Chemokine Ligand 2 (CCL2) Link Obesity to a Pro-Inflammatory State?
by: Sebastian Dommel, et al.
Published: (2021-02-01)

External validation of urinary C–C motif chemokine ligand 14 (CCL14) for prediction of persistent acute kidney injury
by: Sean M. Bagshaw, et al.
Published: (2021-05-01)

Renin angiotensin system molecules and chemokine (C-C motif) ligand 2 (CCL2) in chronic kidney disease patients
by: Isabella Viana Gomes Schettini, et al.
Published: (2021-07-01)

Adipose-specific C-C motif chemokine ligand (CCL) 19 overexpression drives the mice to both insulin resistance and weight gain
by: Yuki Nishimura, et al.
Published: (2021-08-01)

C-X-C Motif Chemokine Ligand 1 Promotes Colitis by Modulating the Gut Microbiota
by: Hang Zhao, et al.
Published: (2023-12-01)

Isolation and Characterization of C-C Chemokine Ligand 7 (CCL7) in Cynomolgus Macaques
by: Sela S. Mariya, et al.
Published: (2019-12-01)

Chemokine C-C Motif Ligand 7 (CCL7), a Biomarker of Atherosclerosis, Is Associated with the Severity of Alopecia Areata: A Preliminary Study
by: Anna Waśkiel-Burnat, et al.
Published: (2021-11-01)

Astrocytic C–X–C motif chemokine ligand-1 mediates β-amyloid-induced synaptotoxicity
by: Beatriz G. Perez-Nievas, et al.
Published: (2021-12-01)

The Significance of Selected C-C Motif Chemokine Ligands in Colorectal Cancer Patients
by: Monika Zajkowska, et al.
Published: (2022-03-01)

C-X3-C motif chemokine ligand 1/receptor 1 regulates the M1 polarization and chemotaxis of macrophages after hypoxia/reoxygenation injury
by: Shuiming Guo, et al.
Published: (2021-12-01)

Exploring the Cost-Utility of a Biomarker Predicting Persistent Severe Acute Kidney Injury: The Case of C-C Motif Chemokine Ligand 14 (CCL14)
by: Echeverri J, et al.
Published: (2024-01-01)

The Roles of C-X-C Motif Chemokine Ligand 10 (CXCL10) in Dengue
by: Siti Noraihan Khamis, et al.
Published: (2022-09-01)

Variants of C-C motif chemokine 22 (CCL22) are associated with susceptibility to atopic dermatitis: case-control studies.
by: Tomomitsu Hirota, et al.
Published: (2011-01-01)

Chemokine (C-C Motif) Ligand 8 and Tubulo-Interstitial Injury in Chronic Kidney Disease
by: Jangwook Lee, et al.
Published: (2022-02-01)

Multifaceted Roles of Chemokine C-X-C Motif Ligand 7 in Inflammatory Diseases and Cancer
by: Qianmiao Wu, et al.
Published: (2022-06-01)

Plasma Chemokine C-C Motif Ligand 2 as a Potential Biomarker for Prostate Cancer
by: Lund M, et al.
Published: (2022-02-01)

Cancer-Associated Fibroblasts Promote Tumor Aggressiveness in Head and Neck Cancer through Chemokine Ligand 11 and C-C Motif Chemokine Receptor 3 Signaling Circuit
by: Wen-Yen Huang, et al.
Published: (2022-06-01)

Partial agonist activity of α1-adrenergic receptor antagonists for chemokine (C-X-C motif) receptor 4 and atypical chemokine receptor 3.
by: Xianlong Gao, et al.
Published: (2018-01-01)

Blocking postsynaptic density-93 binding to C-X3-C motif chemokine ligand 1 promotes microglial phenotypic transformation during acute ischemic stroke
by: Xiao-Wei Cao, et al.
Published: (2023-01-01)

Chemokine (C-C motif) ligand 20, a potential biomarker for Graves' disease, is regulated by osteopontin.
by: Xiaoli Li, et al.
Published: (2013-01-01)

On the Role of Paraoxonase-1 and Chemokine Ligand 2 (C-C motif) in Metabolic Alterations Linked to Inflammation and Disease. A 2021 Update
by: Jordi Camps, et al.
Published: (2021-07-01)

Activation of thromboxane A2 receptor (TP) increases the expression of monocyte chemoattractant protein -1 (MCP-1)/chemokine (C-C motif) ligand 2 (CCL2) and recruits macrophages to promote invasion of lung cancer cells.
by: Xiuling Li, et al.
Published: (2013-01-01)

Bovine C-X-C Motif Chemokine Ligand 14 Expression Is Regulated by Alternative Polyadenylation and MicroRNAs
by: Wei Zhao, et al.
Published: (2023-09-01)

Serial Urinary C-C Motif Chemokine Ligand 14 and Risk of Persistent Severe Acute Kidney Injury
by: John R. Prowle, MD, et al.
Published: (2023-03-01)

C–X–C motif chemokine ligand 12: a potential therapeutic target in Duchenne muscular dystrophy
by: Jie Chen, et al.
Published: (2021-01-01)

Urine hepcidin, netrin-1, neutrophil gelatinase-associated lipocalin and C-C motif chemokine ligand 2 levels in multicystic dysplastic kidney
by: Nuran Cetin, et al.
Published: (2020-08-01)

C–C motif chemokine CCL11 is a novel regulator and a potential therapeutic target in non-alcoholic fatty liver disease
by: Zhiwen Fan, et al.
Published: (2023-09-01)

Is the C-C Motif Ligand 2–C-C Chemokine Receptor 2 Axis a Promising Target for Cancer Therapy and Diagnosis?
by: Hiroaki Iwamoto, et al.
Published: (2020-12-01)

Analysis of urinary C–C motif chemokine ligand 14 (CCL14) and first-generation urinary biomarkers for predicting renal recovery from acute kidney injury: a prospective exploratory study
by: Ben-Shu Qian, et al.
Published: (2023-03-01)

CX3CL1/CX3CR1 and CCL2/CCR2 chemokine/chemokine receptor complex in patients with AMD.
by: Mads Krüger Falk, et al.
Published: (2014-01-01)

Elevated Serum Levels of Monocyte Chemotactic Protein-1/Chemokine C-C Motif Ligand 2 are Linked to Disease Severity in Patients with Fibromyalgia Syndrome
by: Yuan-Chuang Zhao, et al.
Published: (2019-11-01)

Dephosphorylation of Caveolin-1 Controls C-X-C Motif Chemokine Ligand 10 Secretion in Mesenchymal Stem Cells to Regulate the Process of Wound Healing
by: Panpan Wang, et al.
Published: (2021-11-01)

C-C Motif Chemokine Ligand-17 as a Novel Biomarker and Regulator of Epithelial Mesenchymal Transition in Renal Fibrogenesis
by: Yi-Hsien Hsieh, et al.
Published: (2021-11-01)